ESC 365 - Inflammation in stable atherosclerotic cardiovascular disease (ASCVD): what impact does it have?

Open Access

Inflammation in stable atherosclerotic cardiovascular disease (ASCVD): what impact does it have?

Session: Systemic inflammation in stable and unstable ischaemic heart disease (IHD): connecting the dots

Topic: Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis

Speaker: Doctor P. Ridker (Boston, US)

Sponsored by Novo Nordisk A/S

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

37 presentations

7 followers

4 more presentations in this session

Opening & welcome

Speaker: Doctor P. Ridker (Boston, US)

Inflammation in acute myocardial infarction (AMI): where do we stand?

Speaker: Professor R. Mehran (New York, US)

High-sensitivity C-reactive protein: how can it guide cardiovascular risk assessment?

Speaker: Professor F. Kahles (Aachen, DE)

Panel discussion and Q&A

Access the full session

Systemic inflammation in stable and unstable ischaemic heart disease (IHD): connecting the dots

Speakers: Doctor P. Ridker, Doctor P. Ridker, Professor R. Mehran, Professor F. Kahles

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources